Forefront Analytics’s Vaxart VXRT Stock Holding History

Forefront Analytics’s Portfolio VXRT Stock Details VXRT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-18,250	Closed	-$106K	–	74
2020 Q4	$106K	Buy	+18,250	New	+$116K	0.05%	58

Other funds holding VXRT

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Forefront Analytics's VXRT Position: Q1 2021 in Review

Forefront Analytics sold out of Vaxart (VXRT) in Q1 2021, closing a stake of 18,250 shares — an estimated $106K sold.

Forefront Analytics first reported a position in VXRT in Q4 2020 and held it in 1 quarter. The position peaked at $106K in Q4 2020. 159 funds tracked by Wall St. Rank hold VXRT as of Q1 2021.

Forefront Analytics reported no remaining Vaxart position as of Q1 2021 after selling out during the quarter.
Forefront Analytics sold 18,250 Vaxart shares in Q1 2021, an estimated $106K.
Forefront Analytics first reported a position in Vaxart in Q4 2020 and held it in 1 quarter.
Forefront Analytics's Vaxart position peaked at $106K in Q4 2020.
159 funds tracked by Wall St. Rank held Vaxart as of Q1 2021.

Based on Forefront Analytics's 13F filing for Q1 2021, filed 13 May 2021.